ABBV

ABBVIE INC.
$217.72 -0.42%

Recent alerts on ABBV

All signals →
News State Street's Health Care ETF Tops Invesco's on Yield and Returns
2h ago
News AbbVie gains EU approval of atogepant for acute migraine
3h ago
News AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
19h ago
News Ironwood, AbbVie win U.S. label expansion for Linzess in pediatric constipation
5d ago
News Prediction: These 2 Obesity Drug Stocks Could Double in 2026
7d ago
News AbbVie, Merck, Astra among winners of EU drug recommendations this week
10d ago
News Merck Just Made a Big Bet on a New Cancer Growth Engine
14d ago
News Why AbbVie Stock Cruised to an Almost 6% Gain Today
14d ago
News 1 Green Flag for AbbVie (ABBV) Stock Right Now
14d ago
News Deal Dispatch: PepsiCo, Sycamore, Dr. Phil, SSENSE, Bain's Chindata Lead M&A, Bankruptcy Moves
14d ago
News Healthcare Valuations Near Multi-Year Lows Suggest Risk–Reward Asymmetry
14d ago
News AbbVie's Patch Baldness Study Finds High Hair Coverage Rates With Investigational Drug Upadacitinib
14d ago
News AbbVie Strikes $1.2 Billion Agreement For Next-Gen Psychedelic Depression Treatment
14d ago
News As the Market Rotates, This Healthcare ETF Is Leading the Way
14d ago
News AbbVie Inclusion In Medicare Drug Talks Fails To Justify Lawsuit, Court Rules
14d ago
News AbbVie Soars On Skyrizi And Rinvoq Strength, Outpacing Humira Erosion
14d ago
News AbbVie Raises 2025 Outlook After Q2 Beat
14d ago
News AbbVie Lifts Outlook, Eyes Parkinson's Assets As Next Growth Frontier
14d ago
News The Best High-Yield Dividend ETF to Own for the Next 10 Years
14d ago
News Want Decades of Passive Income? Buy This Index Fund and Hold It Forever.
14d ago
News Novartis' Cosentyx Fails Late-Stage Giant Cell Arteritis Trial
14d ago
News Why Is AbbVie Stock Trading Higher On Thursday?
14d ago
News Meta, JPMorgan, Gap And A Health Care Stock On CNBC's 'Final Trades'
14d ago
News FDA Expands AbbVie's Mavyret Label To Include Acute Hepatitis C Treatment (CORRECTED)
14d ago
News AbbVie's Cancer Drug Venetoclax Falls Short In Phase 3 Combination Trial For Myelodysplastic Syndromes
14d ago

Get push alerts for ABBV

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS